[Breakout Alert] This Biotech Stock Just Hit Critical Mass

Hey Trader,

I just got word from Ross Givens that he's spotted a hot new trade opportunity that he believes has the potential to gain as much as 207% in a matter of months.

It's a small biotech stock that just took a significant tumble after a disappointing drug trial…

But there are several key reasons why Ross believes this dip is a drastic overreaction… 

And why right now is the time to get in. 

He posted a video to give you all the juicy details… 

Watch it right here!

To big profits and beyond, 

Anthony Speciale Jr

Editor & Chief Investment Strategist,

Big Energy Profits


team1@hawkeyetraders.com
hawkeyetraders.com


Call us: (888) 233-8598

DISCLAIMER: * Futures, stocks, and spot currency trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures, stocks, and forex markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures, stocks or forex. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. Past performance of indicators or methodology are not necessarily indicative of future results.

CFTC Regulation 4.41 These results are based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to these being shown.

We'll always treat your personal information with the utmost care and will never sell it to third parties. You can find out more about what data we hold about you, why we need it, and how we keep that information safe in our Privacy Policy.

No comments:

Post a Comment